(:RWLK)

Mar 22, 2024 08:30 am ET
VA STAND Act introduced in the United States Senate
ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the...
Mar 13, 2024 11:45 am ET
Lifeward Announces Reverse Share Split
ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the...
Mar 08, 2024 08:30 am ET
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the...
Mar 01, 2024 08:45 am ET
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the curr
ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the...
Feb 27, 2024 08:00 am ET
Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results
ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the...
Feb 20, 2024 08:30 am ET
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the...
Jan 29, 2024 08:00 am ET
ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”) today unveiled its new corporate branding to officially begin doing business as Lifeward™ (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what...
Jan 15, 2024 08:47 am ET
Sidoti Events, LLC's Virtual January Micro-Cap Conference
NEW YORK, NY / ACCESSWIRE / January 16, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day January Micro-Cap Conference taking place Wednesday and Thursday, January 17-18, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Jan 12, 2024 08:30 am ET
ReWalk Robotics Expands Direct Sales Coverage to Canada
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, announced today that the...
Jan 11, 2024 05:00 pm ET
ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will provide an overview presentation and host one-on-one meetings with investors at...
Jan 05, 2024 08:00 am ET
First ReWalk Personal Exoskeleton Claim Paid by Medicare
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced that it has received...
Jan 04, 2024 08:00 am ET
ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), today issued an open letter from Larry Jasinski, Chief Executive Officer, to shareholders detailing transformational achievements in 2023 and commercial and operating priorities for...
Nov 30, 2023 04:45 pm ET
ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, presented at the...
Nov 28, 2023 08:00 am ET
ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, announced the...
Nov 14, 2023 08:06 am ET
ReWalk Robotics Reports Third Quarter 2023 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its...
Nov 10, 2023 08:30 am ET
New Bill Facilitates Veteran Access to Powered Exoskeletons
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, applauded new...
Nov 07, 2023 08:00 am ET
ReWalk Robotics to Discuss Medicare’s Preliminary Payment Determination for ReWalk Personal Exoskeleton
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced that...
Nov 07, 2023 07:40 am ET
ReWalk Robotics to Report Third Quarter 2023 Financial Results on November 14, 2023
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2023 financial results on Tuesday, November 14, 2023, prior to the U.S. financial markets open. Larry Jasinski, Chief...
Nov 06, 2023 08:00 am ET
In Historic Move, Medicare Proposes Preliminary Reimbursement Level for ReWalk Personal Exoskeleton
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced that the...
Nov 02, 2023 08:00 am ET
Medicare Coverage Solidified for ReWalk Personal Exoskeleton
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its...
Oct 18, 2023 08:30 am ET
ReWalk Robotics Exhibits at the GITEX GLOBAL Intelligent Connectivity / AI Pavilion
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced that...
Sep 20, 2023 08:00 am ET
ReWalk Robotics Offers Thanks to Former Director for His Loyal Service and Valuable Contributions
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its...
Sep 06, 2023 08:00 am ET
ReWalk Robotics Ltd. to Present Virtually at H.C. Wainwright 25th Annual Global Investment Conference
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that Larry Jasinski, Chief Executive Officer, will present and host one-on-one meetings with investors virtually at the H.C. Wainwright 25th Annual Global Investment...
Sep 05, 2023 08:30 am ET
ReWalk Robotics Announces Additional Change to Board of Directors
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced that...
Aug 11, 2023 04:15 pm ET
ReWalk Robotics Announces Closing of Acquisition of AlterG
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced closing...
Aug 11, 2023 08:00 am ET
ReWalk Robotics Reports Second Quarter 2023 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its...
Aug 08, 2023 04:15 pm ET
ReWalk Robotics to Acquire AlterG; Acquisition Builds Commercial Scale and Accelerates Path to Profitability
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced the execution of a...
Aug 03, 2023 04:15 pm ET
ReWalk Robotics to Report Second Quarter Financial Results on August 11, 2023
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that the Company will release its second quarter 2023 financial results before the markets open on Friday, August 11, 2023. Larry Jasinski, Chief Executive Officer, and...
Jul 28, 2023 04:15 pm ET
ReWalk Robotics Announces Planned Changes to Board of Directors
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced that two...
Jul 11, 2023 05:30 pm ET
ReWalk Robotics Ltd. to Present at the Emerging Growth Conference on July 12
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”) announced Larry Jasinski, Chief Executive Officer, will present virtually at the Emerging Growth Conference at 10:15 am EDT on Wednesday, July 12, 2023. For investors who are...
Jul 11, 2023 07:00 am ET
Presenting on the Emerging Growth Conference on July 12 & 13 Register Now
EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 60th Emerging Growth Conference on July 12 & 13, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with...
Jul 05, 2023 08:30 am ET
ReWalk Robotics Ltd. to Host Call to Discuss Medicare Proposal to Establish Personal Exoskeletons Within a Benefit Category for Eligible Beneficiaries
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, announced that it will...
Jun 30, 2023 04:58 pm ET
ReWalk Robotics Applauds Medicare Proposal to Include Personal Exoskeletons in a Medicare Benefit Category to be Paid on a Lump Sum Basis
ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, applauds the Centers for...
May 11, 2023 08:00 am ET
ReWalk Robotics Reports First Quarter 2023 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its...
May 04, 2023 08:30 am ET
ReWalk Robotics to Provide First U.S. Demonstrations of Groundbreaking Stairs-Enabled Exoskeleton Technology
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “The Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced the...
May 03, 2023 04:30 pm ET
ReWalk Robotics Ltd. to Report First Quarter Financial Results on May 11, 2023
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that the Company will release its first quarter 2023 financial results before the markets open on Thursday, May 11, 2023. Larry Jasinski, Chief Executive Officer, and...
May 03, 2023 08:30 am ET
ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on May 10
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will present and host one-on-one meetings with investors at the Sidoti May Virtual...
Mar 07, 2023 08:00 am ET
Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs
ReWalk Robotics Ltd., (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, announced today that...
Feb 23, 2023 08:00 am ET
ReWalk Robotics Reports Fourth Quarter and Full Year 2022 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a medical device company that designs, develops, and commercializes innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with...
Feb 16, 2023 08:00 am ET
ReWalk Robotics to Report Fourth Quarter and Fiscal Year-End 2022 Financial Results on February 23, 2023
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter and fiscal year-end 2022 financial results on Thursday, February 23, 2023, at 8:30 AM Eastern time. Larry Jasinski,...
Jan 05, 2023 08:30 am ET
“Modern Miracles”: ReWalk Technology Showcased at the Hanukkah Celebration Hosted by the Embassy of the State of Israel to Belgium and Luxembourg in Antwerp
ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a manufacturer of robotic medical devices for individuals with lower limb disabilities, had the honor to present its technology at the prestigious event hosted by the Embassy of the...
Dec 22, 2022 08:00 am ET
ReWalk Announces Extension of Share Repurchase Program
ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that its Board of Directors (the “Board”) has approved an extension...
Nov 11, 2022 08:00 am ET
Germany’s second largest health insurer withdraws appeal with Federal Social Court, accepts prior ruling of exoskeletons as direct disability compensation
ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), today welcomed the decision by BARMER to accept the prior ruling from the state court that exoskeletons are considered as direct disability compensation and withdraw the pending case...
Nov 07, 2022 08:00 am ET
ReWalk Robotics Reports Third Quarter 2022 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced its financial results for the three and nine months ended September...
Oct 31, 2022 04:15 pm ET
ReWalk Robotics to Report Third Quarter 2022 Financial Results on November 7, 2022
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2022 financial results on Monday, November 7, 2022, at 8:30 AM Eastern time. Larry Jasinski, Chief Executive Officer,...
Sep 28, 2022 07:15 am ET
ReWalk Takes Another Step Toward Medicare Coverage
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”, or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, is announcing that the Company will begin submitting Medicare cases following CMS’s...
Sep 12, 2022 08:00 am ET
German Federal Social Court Schedules Hearing on Classification of Exoskeleton Medical Devices for Spinal Cord Injured Individuals
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the German Federal Social Court has scheduled a hearing to review...
Sep 08, 2022 08:30 am ET
ReWalk Robotics Appoints Michael Lawless as Chief Financial Officer
ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the appointment of Michael Lawless, CPA, as Chief Financial Officer,...
Aug 09, 2022 08:00 am ET
ReWalk Robotics Reports Second Quarter 2022 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and six months ended June 30, 2022. Highlights of and subsequent to the second quarter of 2022 include: Total revenue for the...
Aug 03, 2022 08:00 am ET
ReWalk Robotics to Report Second Quarter 2022 Financial Results on August 9, 2022
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2022 financial results on Tuesday, August 9, 2022, at 8:30 AM Eastern time. Larry Jasinski, Chief Executive Officer,...
Aug 02, 2022 04:30 pm ET
ReWalk Robotics Announces Results of 2022 Annual Meeting
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the results of the Company's 2022 Annual Meeting of Shareholders...
Jul 21, 2022 08:00 am ET
ReWalk Receives Court Approval for Share Repurchase Program
ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that it has received Israeli court approval to repurchase up to $8...
Jun 23, 2022 08:00 am ET
100th ReWalk Exoskeleton Supplied in Germany
ReWalk Robotics, Ltd (Nasdaq: RWLK) ("ReWalk" or "the Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, announces the 100th placement of an exoskeleton in Germany. The first official...
Jun 10, 2022 04:15 pm ET
ReWalk Provides Notice of 2022 Annual Meeting of Shareholders
ReWalk Robotics Ltd. (Nasdaq: RWLK), (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today provided notice that the 2022 Annual Meeting of Shareholders (the “Meeting”) will be held on Wednesday, July 27, 2022, at 10:00 a.m. EDT at the Hyatt Place Marlborough / Apex Center Hotel in Marlborough, Massachusetts.
Jun 02, 2022 08:00 am ET
ReWalk Robotics Announces Share Repurchase Program
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that its Board of Directors (the “Board”) has approved a program to...
May 26, 2022 04:10 pm ET
ReWalk Robotics Files Revised Preliminary Proxy Statement and Issues Letter to Shareholders
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that it has filed its revised preliminary proxy statement with the...
May 19, 2022 07:55 am ET
ReWalk Robotics Confirms Receipt of Director Candidate Nominations from Creative Value Capital
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that it has received notice from Creative Value Capital Limited...
May 13, 2022 04:05 pm ET
ReWalk Robotics Reports First Quarter 2022 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three months ended March 31, 2022. Highlights of and subsequent to the first quarter of 2022 include: Total revenue for the first...
May 09, 2022 04:15 pm ET
ReWalk Robotics to Report First Quarter 2022 Financial Results on May 13, 2022
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its first quarter 2022 financial results on Friday, May 13, 2022, after the U.S. financial markets close.    Larry Jasinski, Chief...
Apr 29, 2022 08:30 am ET
ReWalk Joins Israeli Technology Innovation Consortium for Human-Robot Interaction
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced its membership in the Human Robot Interaction (HRI) Consortium,...
Apr 20, 2022 04:05 pm ET
ReWalk Robotics Announces the Appointment of Joseph E. Turk, Jr. to their Board of Directors
ReWalk Robotics. Ltd. (NASDAQ: RWLK) (“ReWalk” or “The Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, announced today that the Board has approved the appointment of Joseph Turk, Jr. to...
Mar 24, 2022 08:15 am ET
ReWalker Sets Guinness World Record for Climbing a London Skyscraper While Wearing an Exoskeleton
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced Simon Kindleysides, a British man who is paralyzed from the waist...
Feb 24, 2022 07:00 am ET
ReWalk Robotics Reports Fourth Quarter and Year End 2021 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and twelve-months ended December 31, 2021. Highlights of and subsequent to the fourth quarter and FY 2021 include: Annual revenue...
Feb 21, 2022 07:00 am ET
ReWalk Robotics to Report Fourth Quarter 2021 Financial Results on February 24, 2022
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter 2021 financial results on Thursday, February 24, 2022, before the U.S. financial markets open.    Larry Jasinski,...
Jan 28, 2022 07:36 am ET
Thinking about buying stock in NeoGenomics, Provention Bio, Exela Technologies, Braskem SA, or Rewalk Robotics?
NEW YORK, Jan. 28, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NEO, PRVB, XELA, BAK, and RWLK.
Jan 06, 2022 08:00 am ET
ReWalk Robotics to Present at the H.C. WAINWRIGHT BioConnect Virtual Conference
ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer and Ori Gon, Chief Financial Officer will present at H.C.WAINWRIGHT BioConnect virtual conference taking place January...
Nov 12, 2021 04:05 pm ET
ReWalk Robotics to Present at the H.C. WAINWRIGHT 7th Annual Israel Virtual Conference
ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer and Ori Gon, Chief Financial Officer will present at H.C.WAINWRIGHT 7th annual Israel virtual conference held on November...
Nov 11, 2021 07:51 am ET
Thinking about buying stock in Opendoor Technologies, Rewalk Robotics, Compugen, SoFi Technologies, or Lordstown Motors?
NEW YORK, Nov. 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OPEN, RWLK, CGEN, SOFI, and RIDE.
Nov 10, 2021 04:30 pm ET
ReWalk Robotics Reports Third Quarter 2021 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and nine months ended September 30, 2021. Highlights of and subsequent to the third quarter of 2021 include: Total revenue of $2.0...
Nov 05, 2021 04:36 pm ET
ReWalk Robotics to Hold its Third Quarter 2021 Earnings Call on November 11, 2021
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that management will hold its third quarter 2021 earnings call Thursday, November 11, 2021, at 8:30 AM Eastern time.  To access the conference call please dial the...
Nov 05, 2021 08:30 am ET
Thinking about buying stock in Assertio, Rewalk Robotics, Ontrak, Bigcommerce, or Codexis?
NEW YORK, Nov. 5, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ASRT, RWLK, OTRK, BIGC, and CDXS.
Nov 04, 2021 04:30 pm ET
FDA Awards Breakthrough Device Designation to the ReWalk ReBoot Soft Exo-Suit
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading global manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced its ReBoot device has been granted designation as a...
Sep 29, 2021 04:05 pm ET
ReWalk Robotics Announces Closing of $32.5 Million Registered Direct Offering Priced At Premium to Market
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, for the sale of 16,013,518 of the Company’s ordinary shares...
Sep 28, 2021 10:40 am ET
Thinking about buying stock in Farmmi, Naked Brand, Southwestern Energy, Altimmune, or Rewalk Robotics?
NEW YORK, Sept. 28, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FAMI, NAKD, SWN, ALT, and RWLK.
Sep 27, 2021 10:55 am ET
Thinking about buying stock in Camber Energy, Rewalk Robotics, vTv Therapeutics, Quantumscape, or Northern Dynasty Minerals?
NEW YORK, Sept. 27, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CEI, RWLK, VTVT, QS, and NAK.
Sep 27, 2021 08:00 am ET
ReWalk Robotics Announces $32.5 Million Registered Direct Offering Priced At Premium to Market
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with several institutional investors providing for the issuance of 16,013,518 of the Company’s ordinary shares (or...
Sep 24, 2021 08:31 am ET
Thinking about buying stock in Capricor Therapeutics, vTv Therapeutics, Li-Cycle Holdings, Predictive Oncology, or Rewalk Robotics?
NEW YORK, Sept. 24, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CAPR, VTVT, LICY, POAI, and RWLK.
Sep 23, 2021 10:55 am ET
Thinking about buying stock in Aterian, Lucid Group, Senmiao Technology, Four Seasons Edu, or Rewalk Robotics?
NEW YORK, Sept. 23, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATER, LCID, AIHS, FEDU, and RWLK.
Sep 22, 2021 10:40 am ET
Thinking about buying stock in Rewalk Robotics, Camber Energy, BIO-key International, MGM Resorts, or Freeport-McMoRan?
NEW YORK, Sept. 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RWLK, CEI, BKYI, MGM, and FCX.
Sep 21, 2021 08:30 am ET
Thinking about buying stock in Rewalk Robotics, Viridian Therapeutics, CohBar, Golden Ocean Group, or Indie Semiconductor?
NEW YORK, Sept. 21, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RWLK, VRDN, CWBR, GOGL, and INDI.
Aug 09, 2021 07:00 am ET
ReWalk Robotics Reports Second Quarter 2021 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and six months ended June 30, 2021. Highlights of and subsequent to the second quarter of 2021 include: Total revenue in the...
Aug 04, 2021 04:35 pm ET
ReWalk Robotics to Report Second Quarter 2021 Financial Results on August 9, 2021
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2021 financial results on Monday, August 9, 2021, before the U.S. financial markets open. Larry Jasinski, Chief...
Aug 02, 2021 07:34 am ET
ReWalk Robotics Appoints Senior Biotech Executive, Jeannine Lynch, as Vice President of Strategy and Market Access
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced Jeannine Lynch will join the Company on August 31, 2021, as Vice President of...
May 11, 2021 07:23 am ET
ReWalk Robotics Reports First Quarter 2021 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three months ended March 31, 2021. Highlights of and subsequent to the first quarter of 2021 include: The Company’s total revenue in the...
May 07, 2021 04:58 pm ET
ReWalk Robotics to Report First Quarter 2021 Financial Results on May 11, 2021
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its first quarter 2021 financial results on Tuesday, May 11, 2021, before the U.S. financial markets open.    Larry Jasinski, Chief...
Mar 04, 2021 04:30 pm ET
ReWalk Robotics to Present at the H.C. WAINWRIGHT Global Life Sciences Virtual Conference
ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer and Ori Gon, Chief Financial Officer will present at H.C.WAINWRIGHT global life science conference held on March 9 – 10,...
Feb 26, 2021 12:41 pm ET
ReWalk Robotics Announces Closing of $40.0 Million Private Placement Priced At-the-Market
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced private placement of 10,921,502 ordinary shares and warrants to purchase up to 5,460,751 ordinary shares, at a purchase price...
Feb 19, 2021 05:02 pm ET
ReWalk Robotics Announces $40.0 Million Private Placement Priced At-the-Market
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into securities purchase agreements with certain institutional and other accredited investors to raise $40.0 million through the issuance of...
Feb 18, 2021 07:00 am ET
ReWalk Robotics Reports Fourth Quarter and Year End 2020 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and twelve-months ended December 31, 2020. Highlights of and subsequent to the fourth quarter and FY 2020 include: Q4 2020...
Feb 15, 2021 12:44 pm ET
ReWalk Robotics to Report Fourth Quarter 2020 Financial Results on February 18, 2021
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter 2020 financial results on Thursday, February 18, 2021, before the U.S. financial markets open.    Larry Jasinski,...
Jan 06, 2021 08:00 am ET
ReWalk Robotics Repays Outstanding Balance on Kreos Credit Line
ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or the “Company”) today announced that it has repaid in full the outstanding balance on its credit line from Kreos Capital V (Expert Fund) Limited (“Kreos”). The final payment was made on December 29,...
Dec 21, 2020 03:45 pm ET
ReWalk Robotics Donates ReStore Exo-Suit to Brooks Rehabilitation to Support Stroke Survivors
MARLBOROUGH, Mass., Dec. 21, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced it has donated one of its ReStore Exo-suits to Brooks Rehabilitation, located in Jacksonville, Florida. The ReStore will be utilized by the therapy team in one of the the specialized Neuro Recovery Centers to conduct gait training sessions with patients seeking post-stroke rehabilitation.
Dec 10, 2020 08:31 am ET
Thinking about buying stock in Pfizer, Rewalk Robotics, Veru, Arbutus Biopharma, or Plug Power?
NEW YORK, Dec. 10, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE, RWLK, VERU, ABUS, and PLUG.
Dec 10, 2020 07:00 am ET
Leading German Private Health Insurer Enters Contract to Provide ReWalk Exoskeletons to Individuals with Spinal Cord Injuries
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for people with lower extremity disabilities, today announced it has entered into a contract with a German private health insurance...
Dec 08, 2020 04:30 pm ET
ReWalk Robotics Announces Closing of $8.0 Million Private Placement Priced At-the-Market
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), today announced the closing of its previously announced private placement of 5,579,776 ordinary shares and warrants to purchase up to 4,184,832 ordinary shares, at a purchase price of...
Dec 03, 2020 09:15 am ET
ReWalk Robotics Announces $8.0 Million Private Placement Priced At-the-Market
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), today announced that it has entered into securities purchase agreements with certain institutional and other accredited investors to raise $8.0 million through the issuance of...
Nov 10, 2020 07:00 am ET
ReWalk Robotics Reports Third Quarter 2020 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and nine months ended September 30, 2020. Highlights of and subsequent to the third quarter of 2020 include: Total revenue for the...
Nov 09, 2020 07:00 am ET
ReWalk Robotics to Present at the H.C. WAINWRIGHT 6th Annual Israel Virtual Conference on November 12th, 2020
ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer, Ori Gon Chief Financial Officer and Andy Dolan, VP Marketing and Reimbursement will present a fireside chat at the...
Nov 06, 2020 09:00 am ET
ReWalk Robotics to Report Third Quarter 2020 Financial Results on November 10, 2020
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2020 financial results on Tuesday, November 10, 2020, before the U.S. financial markets open.    Larry Jasinski,...
Oct 20, 2020 08:31 am ET
ReWalk Robotics Receives Medicare Provider Certification
MARLBOROUGH, Mass., Oct. 20, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced that the Centers for Medicare & Medicaid Services ("CMS") authorized the Company as a Medicare Provider. With this certification, the Company can now bill Medicare directly for procurement of its ReWalk Personal Exoskeleton for Medicare beneficiaries and is now listed in the Medicare.gov Supplier Directory.
Oct 19, 2020 07:01 am ET
ReWalk Robotics announces the Appointment of Randel E. Richner, BSN, MPH to its Board of Directors
ReWalk Robotics. Ltd. (NASDAQ: RWLK) (“ReWalk” or the “Company”) announced today that the Company has approved the appointment of Randel Richner to the Board of Directors, effective November 1, 2020. Ms. Richner’s extensive history experience in...
Oct 16, 2020 09:31 am ET
Thinking about buying stock in Rewalk Robotics, Selecta Biosciences, Aphria, Plug Power, or Aslan Pharmaceuticals?
NEW YORK, Oct. 16, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RWLK, SELB, APHA, PLUG, and ASLN.
Sep 10, 2020 05:00 pm ET
ReWalk Robotics to Present at the H.C. WAINWRIGHT 22nd Annual Global Investment Virtual Conference on September 15th, 2020
ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer, Ori Gon, Chief Financial Officer and Andy Dolan, VP Marketing and Reimbursement, will present at the H.C. WAINWRIGHT...
Aug 27, 2020 07:00 am ET
U.S. Court of Appeals Dismisses Securities Lawsuit Against ReWalk Robotics
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced that the U.S. Court of Appeals for the First Circuit dismissed a class...
Aug 12, 2020 07:00 am ET
ReWalk Robotics Reports Second Quarter 2020 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and six months ended June 30, 2020. Highlights of and subsequent to the second quarter of 2020 include: Total revenue for the...
Aug 07, 2020 08:00 am ET
ReWalk Robotics to Report Second Quarter 2020 Financial Results on August 12, 2020
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2020 financial results on Wednesday, August 12, 2020, before the U.S. financial markets open. Larry Jasinski,...
Jul 15, 2020 07:01 am ET
Centers for Medicare & Medicaid Services Issues Code for ReWalk Personal Exoskeleton
MARLBOROUGH, Mass., July 15, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced the Centers for Medicare and Medicaid Services ("CMS") issued Healthcare Common Procedure Coding System ("HCPCS") Level II Code K1007 in response to the Company's application. This decision, which will be effective on October 1, 2020, establishes the first such code for exoskeletons.
Jul 06, 2020 04:10 pm ET
ReWalk Robotics Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced registered direct offering of approximately 4,938,278 of the Company’s ordinary shares, at a purchase price of $1.8225 per...
Jul 01, 2020 06:00 am ET
ReWalk Robotics Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with several institutional investors providing for the issuance of approximately 4,938,278 of the Company’s ordinary...
Jun 22, 2020 04:40 pm ET
ReWalk Announces Publication of ReStore Powered Exo-Suit Clinical Study Results
MARLBOROUGH, Mass., June 22, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced the publication of the results of its multi-center clinical study of the ReStore Exo-Suit for rehabilitation of individuals with lower limb disability due to stroke. The study examined patient safety and explored functional walking outcomes in stroke survivors who completed a series of gait training sessions with the ReStore device. 
Jun 04, 2020 07:30 am ET
ReWalk Robotics Finalizes U.S. Distribution Agreements for Two Additional Neuro Rehabilitation Product Lines
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk," “we” or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, has finalized and moved to implement two separate agreements to distribute additional...
Jun 02, 2020 08:30 am ET
Centers for Medicare & Medicaid Services Issues Positive Preliminary Coding Decision for ReWalk Exoskeleton
MARLBOROUGH, Mass., June 2, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced that the Centers for Medicare and Medicaid Services ("CMS") conducted a public hearing to discuss requests for new billing codes including CMS's positive preliminary decision for ReWalk's request for a Healthcare Common Procedure Coding System (HCPCS) Level II Code. The preliminary decision is an important moment for exoskeleton devices, which to date, have not had a distinct
May 28, 2020 07:30 am ET
ReWalk Robotics Reports First Quarter 2020 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three months ended March 31, 2020. Highlights of and subsequent to the first quarter of 2020 include: Total revenue for the first...
May 26, 2020 04:51 pm ET
ReWalk Robotics to Report First Quarter 2020 Financial Results on May 28, 2020
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its first quarter 2020 financial results on Thursday, May 28, 2020, before the U.S. financial markets open.    Larry Jasinski, Chief...
May 12, 2020 08:01 am ET
ReWalk Announces Binding Offer to Deutsche Gesetzliche Unfallversicherung (DGUV) - German Social Accident Insurance
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel and BERLIN, May 12, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, announced the acceptance of the binding offer by DGUV (Deutsche Gesetzliche Unfallversicherung / The German Social Accident Insurance) to provide qualified spinal cord injury (SCI) patients with the ReWalk 6.0 robotic exoskeleton device. This binding offer applies for the provision of ReWalk Exoskeletons for all insured persons of the 36 different D
Apr 23, 2020 09:23 am ET
ReWalk Enters Agreements with Leading German Insurers TK and DAK-Gesundheit to Provide Coverage of Robotic Exoskeletons for Individuals with Spinal Cord Injuries
MARLBOROUGH, Mass and BERLIN, April 23, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, has announced the finalization of national agreements with top German Statutory Health Insurers ("SHI") Techniker Krankenkasse ("TK") and Deutsche Angestellten-Krankenkasse – Gesundheit ("DAK-Gesundheit"). These new policies will allow any eligible beneficiary with a spinal cord injury ("SCI") to seek procurement of a ReWalk 6.0 exoskeleton system. TK and DAK, representing
Mar 24, 2020 08:00 am ET
ReWalk Letter to Shareholders on COVID-19 and the Potential Impact on Operations
ReWalk Robotics Ltd. (Nasdaq: RWLK) a global leader in Exoskeleton technology for community use and rehabilitation centers, today issued the following letter to shareholders: To All Shareholders: The emerging coronavirus (COVID-19) outbreak...
Mar 18, 2020 08:01 am ET
ReWalk Announces Progress with German Statutory Health Insurer to Provide Coverage of Robotic Exoskeletons for Individuals With Spinal Cord Injuries
MARLBOROUGH, Mass. and BERLIN, March 18, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities has announced the finalization of an agreement with a group of German statutory health insurer (SHI) to allow any eligible beneficiary with a spinal cord injury (SCI) in the country to seek procurement of a ReWalk 6.0 exoskeleton system.
Feb 20, 2020 07:45 am ET
ReWalk Robotics Reports Fourth Quarter and Year End 2019 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and twelve-months ended December 31, 2019. Highlights of and subsequent to the fourth quarter of 2019 include: Total revenue for...
Feb 17, 2020 08:30 am ET
ReWalk Robotics to Report Fourth Quarter and Year-End 2019 Financial Results on February 20, 2020
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter and year-end 2019 financial results on Thursday, February 20, 2020, before the U.S. financial markets open.    Larry...
Feb 10, 2020 04:05 pm ET
ReWalk Robotics Announces Closing of $7.0 Million Public Offering
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing and funding of its previously announced public offering of 4,053,172 units at a price to the public of $1.25 per unit and 1,546,828 pre-funded units at a...
Feb 06, 2020 06:00 am ET
ReWalk Robotics Announces Pricing of $7.0 Million Public Offering
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the pricing of a public offering of 5,600,000 units at a price to the public of $1.25 per unit, for gross proceeds of $7.0 million, before deducting placement agent...
Nov 13, 2019 08:00 am ET
ReWalk Robotics Reports Third Quarter 2019 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and nine months ended September 30, 2019. Highlights of and subsequent to the third quarter of 2019 include: Total revenue for the...
Nov 08, 2019 08:30 am ET
ReWalk Robotics to Report Third Quarter 2019 Financial Results on November 13, 2019
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2019 financial results on Wednesday, November 13, 2019, before the U.S. financial markets open. Larry Jasinski, Chief...
Nov 05, 2019 06:26 pm ET
First Paralyzed American Completes a Marathon Using a ReWalk Exoskeleton
NEW YORK, Nov. 5, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, announced that Retired Army Sargent Theresa Vereline, became the first paralyzed American to successfully complete a marathon, walking the entire 26.2 mile distance of the 2019 New York City Marathon using the Company's ReWalk Personal 5.0 robotic exoskeleton device.
Sep 23, 2019 07:00 am ET
ReWalk Robotics to Present at the Sidoti & Company Conference on September 25th
ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer, will present at the Sidoti & Company Conference in New York City as follows: Date:Wednesday, September 25, 2019Time:08:35...
Aug 23, 2019 04:05 pm ET
ReWalk Robotics to Present at the H.C. WAINWRIGHT Conference on September 9th
ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer and Ori Gon Chief Financial Officer, will present at the H.C.WAINWRIGHT Conference in New York City as follows:...
Aug 08, 2019 07:00 am ET
ReWalk Robotics Reports Second Quarter 2019 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and six months ended June 30, 2019. Highlights of and subsequent to the second quarter of 2019 include: Total revenue for the...
Aug 06, 2019 01:42 am ET
ReWalk Robotics to Report Second Quarter 2019 Financial Results on August 8, 2019
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2019 financial results on Thursday, August 8, 2019, before the U.S. financial markets open.    Larry Jasinski, Chief...
Jun 12, 2019 04:35 pm ET
ReWalk Robotics Announces Closing of Registered Direct Offering for $5.0 Million Priced At-the-Market
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced registered direct offering of approximately 833,334 ordinary shares at a purchase price of $6.00 per ordinary share, priced...
Jun 10, 2019 09:10 am ET
ReWalk Robotics Announces Pricing of Registered Direct Offering for $5 Million
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with institutional investors providing for the issuance of approximately 833,334 ordinary shares at a purchase price...
Jun 05, 2019 09:15 am ET
ReWalk Robotics Announces Exercise of Warrants Resulting in Cash Proceeds of $10.8 Million
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), today announced the agreement by several accredited investors of its ordinary share purchase warrants to exercise and purchase 1,446,665 of its ordinary shares at an exercise price of...
May 20, 2019 07:00 am ET
ReWalk Robotics Appoints Chunlin (Allen) Han to its Board of Directors
ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) announced today that the Company has appointed Mr. Chunlin (Allen) Han to the board of directors of the Company (the “Board”). Ms. Ning Cong has departed the Board as of May 14, 2019...
May 07, 2019 07:30 am ET
ReWalk Robotics Reports First Quarter 2019 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three months ended March 31, 2019. Highlights of and subsequent to the first quarter of 2019 include: Total revenue for the first...
May 03, 2019 08:30 am ET
ReWalk Robotics to Report First Quarter 2019 Financial Results on May 7, 2019
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its first quarter 2019 financial results on Tuesday, May 7, 2019, before the U.S. financial markets open.    Larry Jasinski, Chief...
Apr 26, 2019 08:30 am ET
ReWalk Robotics Regains Compliance with Nasdaq Listing Rules 5550(a) and 5550(b)
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has regained compliance with Nasdaq Listing Rules 5550(b) (“Rule 5550(b)”) and 5550(a)(2) (“Rule 5550(a)(2)”). Nasdaq Rule 5550(b)As previously reported on...
Apr 25, 2019 08:30 am ET
ReWalk Announces Regional Blue Cross Blue Shield Plan Beneficiaries Are Winning Requests to Walk Again
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 25, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), announced today that an independent reviewer has declared the ReWalk Personal 6.0 Exoskeleton medically necessary for a paralyzed Mississippi woman. This marks the 17th ReWalk System reimbursed under a regional Blue Cross Blue Shield plan.
Apr 23, 2019 04:30 pm ET
ReWalk Robotics to Present at the ThinkEquity Conference on May 2nd
ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer and Andy Dolan, Vice President of Marketing, will present at the ThinkEquity Conference in New York City as follows:...
Apr 18, 2019 08:30 am ET
Consolidated Research: 2019 Summary Expectations for Stepan, Helius Medical Technologies, ReWalk Robotics, Funko, Alimera Sciences, and Eyenovia — Fundamental Analysis, Key Performance Indications
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Stepan Company (NYSE:SCL), Helius Medical Technologies, Inc. (NASDAQ:HSDT),...
Apr 16, 2019 08:30 am ET
ReWalk Announces First Personal Exoskeleton Provided to Cigna Beneficiary
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 16, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), announced today that the first Cigna Corporation (Cigna) insurance beneficiary has received a ReWalk Personal 6.0 exoskeleton for use at home and in his community.
Apr 05, 2019 04:05 pm ET
ReWalk Robotics Announces Closing of Registered Direct Offering for $4.25 Million Priced At-the-Market
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced registered direct offering of approximately 816,914 ordinary shares at a purchase price of $5.2025 per ordinary share, priced...
Apr 03, 2019 06:34 pm ET
ReWalk Robotics Announces Pricing of Registered Direct Offering for $4,250,000
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with institutional investors providing for the issuance of approximately 816,914 ordinary shares at a purchase price of...
Mar 29, 2019 01:37 pm ET
ReWalk Robotics Completes One-for-Twenty-Five Reverse Share Split
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) reported today that it has completed the reverse share split of ReWalk ordinary share at a ratio of one-for-twenty-five shares, which will take effect on April 1, 2019. The Company...
Feb 25, 2019 04:30 pm ET
ReWalk Robotics Announces Closing of $4.37 Million Public Offering
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing and funding of its previously announced public offering of 19,000,000 ordinary shares at a price to the public of $0.23 per share. The gross proceeds of...
Feb 21, 2019 06:00 am ET
ReWalk Robotics Announces Pricing of $4.37 Million Public Offering of Ordinary Shares
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the pricing of a public offering of 19,000,000 ordinary shares, offered at a price to the public of $0.23 per share, for gross proceeds of approximately $4.37 million,...
Feb 20, 2019 04:01 pm ET
ReWalk Robotics Announces Proposed Public Offering of Ordinary Shares
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it intends to offer and sell, subject to market and other conditions, its ordinary shares in a public offering. The offering is subject to market and other...
Feb 19, 2019 07:02 am ET
ReWalk Announces 510k FDA Submission for ReStore™ Exo-Suit for Stroke Rehabilitation
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 19, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced the submission of its 510k application to the U.S. Food and Drug Administration (FDA) for the ReStore™ exo-suit for gait training during stroke rehabilitation. The 510k application submission marks the next step, and a significant milestone in the process of commercialization.
Feb 13, 2019 07:01 am ET
ReWalk Announces Cigna as First Private U.S. Insurer to Adopt National Policy Change for Coverage of Personal Exoskeleton Devices
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 13, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), disclosed today that Cigna Corporation, a leading global health service company, has revised its policy regarding coverage of exoskeleton medical devices for persons with spinal cord injury (SCI). Cigna, which previously had a non-coverage policy, will now review submissions from beneficiaries on a case-by-case basis to consider providing coverage based on medical criteria. This policy revision is the first of its kind by a major private insurer for ind
Feb 08, 2019 07:00 am ET
ReWalk Robotics Reports Fourth Quarter 2018 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three- and twelve-months ended December 31, 2018. Highlights of and subsequent to the fourth quarter of 2018 include: Completed...
Feb 05, 2019 04:30 pm ET
ReWalk Robotics to Report Fourth Quarter and Year-End 2018 Financial Results on February 8, 2019
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter and year-end 2018 financial results on Friday, February 8, 2019, before the U.S. financial markets open.    Larry...
Jan 14, 2019 07:00 am ET
ReWalk Announces Preliminary Fiscal Year 2018 Revenue
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced preliminary, unaudited revenue for the fiscal year ended December 31, 2018. On a preliminary basis, based on the information currently available, for the fiscal year...
Nov 23, 2018 08:00 am ET
Report: Developing Opportunities within ReWalk Robotics, ImmuCell, SCYNEXIS, Fuel Tech, Garrison Capital, and AMREP — Future Expectations, Projections Moving into 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ReWalk Robotics Ltd (NASDAQ:RWLK), ImmuCell Corporation (NASDAQ:ICCC),...
Nov 20, 2018 06:30 pm ET
ReWalk Robotics Announces Closing of $12.1 Million Public Offering
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced underwritten public offering of 12,401,390 units and 26,259,332 pre-funded units at a price to the public of $0.30 per common...
Nov 16, 2018 05:00 am ET
ReWalk Robotics Announces Pricing of $11.6 Million Public Offering
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the pricing of an underwritten public offering of 38,660,722 units at a price to the public of $0.30 per unit. Each unit contains one ordinary share (or ordinary share...
Nov 15, 2018 07:02 am ET
United Spinal Association Issues Recommendation for Insurers to Consider Powered Exoskeleton Devices Medically Necessary for Paralyzed Individuals
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 15, 2018 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company") applauds United Spinal Association's recommendation, dated November 9, 2018, that health insurance providers consider the use of powered exoskeleton devices as medically necessary for eligible individuals with spinal cord injuries (SCI) in both the institutional and home settings who meet the applicable Food and Drug Administration (FDA) indications for use.
Nov 09, 2018 07:02 am ET
ReWalk Announces Placement of 500th Exoskeleton System
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 9, 2018 /PRNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company") announced today that the company has placed its 500th robotic exoskeleton medical device. The majority of these devices are personal systems used by individuals with spinal cord injury in their homes and communities, while others are located in rehabilitation centers to evaluate and train potential new device owners.
Nov 08, 2018 04:01 pm ET
ReWalk Robotics Reports Third Quarter 2018 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and nine months ended September 30, 2018. Highlights of and subsequent to the third quarter include: The recruitment...
Nov 05, 2018 04:30 pm ET
ReWalk Robotics to Report Third Quarter 2018 Financial Results on November 8, 2018
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2018 financial results on Thursday, November 8, 2018, after the U.S. financial markets close.    Larry Jasinski, Chief...
Aug 28, 2018 05:09 pm ET
ReWalk Robotics (RWLK) Investigated by Block & Leviton LLP For Violations of Federal Securities Laws
BOSTON, Aug. 28, 2018 /PRNewswire/ -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether ReWalk Robotics ("ReWalk" or the "Company") (NASDAQ: RWLK) and certain of its officers and directors violated federal securities laws.
Aug 23, 2018 09:00 am ET
ReWalk Robotics to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6th
ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer, and Ori Gon, Chief Financial Officer, will present at the H.C. Wainwright 20th Annual Global Investment Conference in New...
Aug 14, 2018 07:00 am ET
ReWalk Robotics Reports Second Quarter 2018 Financial Results
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”) today announced its financial results for the three- and six-months ended June 30, 2018. Highlights of and subsequent to the second quarter include: Total revenue for the second...
Aug 10, 2018 07:00 am ET
ReWalk Robotics to Report Second Quarter 2018 Financial Results on August 14, 2018
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”) today announced that the Company will release its second quarter 2018 financial results on Tuesday, August 14, 2018, before the U.S. financial markets open.    Larry Jasinski, Chief...
Jul 30, 2018 08:02 am ET
First U.S. ReWalker to Receive 2nd Exoskeleton System through U.S. Department of Veterans Affairs National Policy
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, July 30, 2018 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company") announced today that Retired Marine Captain Derek Herrera, the first American to obtain a ReWalk Personal system after FDA clearance in 2014, has gained approval to  receive a new exoskeleton system courtesy of the U.S. Department of Veterans Affairs procurement program.
Jul 23, 2018 09:31 am ET
Thinking about buying stock in Apple, General Electric, Hasbro, ReWalk Robotics, or Tesla?
CHICAGO, July 23, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, GE, HAS, RWLK, and TSLA.
Jul 20, 2018 08:02 am ET
U.S. Department of Veterans Affairs Expands Access to ReWalk Exoskeletons for Paralyzed Veterans with Revised National Policy
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, July 20, 2018 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company") announced that the U.S. Department of Veterans Affairs has issued a revision to its national policy on exoskeleton medical device training and procurement for qualifying Veterans with spinal cord injury (SCI). The updated policy includes further guidance on the evaluation process and expands access to training program locations among the VA network and private rehabilitation centers through the VA's Veterans Choice Program.
Jul 19, 2018 07:00 am ET
ReWalk Completes Amendment with Wyss Institute at Harvard University to Extend Agreement to June 2022
ReWalk Robotics, Ltd. (Nasdaq:RWLK) ("ReWalk" or the "Company") announced today that the Company has completed an amendment to the working agreement with the Wyss Institute at Harvard University (Wyss). The key modification was an extension of the...
Jun 28, 2018 08:02 am ET
ReWalk Announces Progress in Clinical Study of ReStore Powered Exo-Suit
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, June 28, 2018 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, announced today that the Institutional Review Boards of five leading U.S. research institutions have approved ReWalk's clinical study of the ReStore soft exo-suit device.
Jun 12, 2018 10:33 am ET
ReWalk Personal 6.0 Exoskeleton Added to the Official German List of Medical Aids
ReWalk Robotics, Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) announced today that the Company’s ReWalk Personal 6.0 Exoskeleton System has been included in the official list of medical aids (Hilfsmittelverzeichnis) by the German National...
May 15, 2018 04:01 pm ET
ReWalk Robotics Receives First Tranche of $5 Million as Part of $20 Million Strategic Investment from Timwell Corporation Limited
ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) announced today that the Company has received the first tranche of $5 million in funding as part of the $20 million strategic investment by Timwell Corporation Limited (“Timwell”), a...
May 10, 2018 04:01 pm ET
ReWalk Robotics Reports First Quarter 2018 Financial Results
ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) today announced its financial results for the three months ended March 31, 2018. Highlights of and subsequent to the first quarter include: On April 30, 2018, ReWalk shareholders...
May 09, 2018 11:30 am ET
ReWalk Robotics to Report First Quarter 2018 Financial Results on May 10, 2018
ReWalk Robotics Ltd. (Nasdaq:RWLK), a leading manufacturer of exoskeleton systems, will release its first quarter 2018 financial results on Thursday, May 10, 2018, after the close of the U.S. financial markets.    Larry Jasinski, Chief Executive...
May 03, 2018 04:30 pm ET
ReWalk Robotics Appoints Yohanan Engelhardt to its Board of Directors and as Chairman of the Audit Committee
ReWalk Robotics, Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) announced today that the Company has appointed Yohanan Engelhardt to the Board of Directors and as Chairman of its Audit Committee. Mr. Engelhardt is a seasoned financial executive...
Apr 03, 2018 08:03 am ET
ReWalk Launches Clinical Study for Its ReStore Soft Exo-Suit System
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 3, 2018 /PRNewswire-USNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic exoskeletons, announced today the official launch of its clinical study of the ReStore soft exo-suit system (ReStore) for the rehabilitation of individuals with lower limb disability due to stroke.  The first clinical study participant began using a ReStore last week at the Spaulding Rehabilitation Hospital in Boston, Massachusetts where the study is being led by a team of researchers from the Boston Universit
Mar 21, 2018 08:02 am ET
Italian Workers Compensation Insurer Issues National Coverage Policy for ReWalk Exoskeletons
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, March 21, 2018 /PRNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk" or "the Company"), a leading manufacturer of robotic exoskeletons, today announced that INAIL, the Italian Ministry of Labor and Social Policy's statutory insurance corporation, has put in place a coverage policy that will provide exoskeleton systems for all qualifying beneficiaries. This policy, the first of its kind in Italy, will provide individuals with spinal cord injury access to obtain their own medical device so that they can stand and walk again. Importantly, the
Mar 08, 2018 06:50 am ET
ReWalk Robotics Reports Fourth Quarter and Year-End 2017 Financial Results
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., March 08, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) today announced its financial results for the three months and year ended December 31, 2017.
Mar 08, 2018 06:30 am ET
ReWalk Robotics Announces $20 Million Strategic Investment from Timwell Corporation Limited
– ReWalk and Timwell to form joint venture to develop, manufacture and market ReWalk products in China –
Mar 06, 2018 04:30 pm ET
ReWalk Robotics to Present at Upcoming Healthcare Conferences
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) today announced that Larry Jasinski, Chief Executive Officer, will present at two upcoming healthcare conference as follows:   
Feb 01, 2018 01:00 am ET
German National Health Insurance Agency Announces Addition of ReWalk 6.0 System to National Medical Device Directory
MARLBOROUGH, Mass. and BERLIN, Feb. 1, 2018 /PRNewswire/ -- GKV-Spitzenverband, the head office of German statutory health insurance (SHI), confirmed their decision to list the ReWalk (Nasdaq: RWLK) Personal 6.0 Exoskeleton System in the German Medical Device Directory (MDD, Hilfsmittelverzeichnis), according to §139 SGB V. The MDD is a comprehensive list of all medical devices which are principally and regularly reimbursed by German SHI providers. This decision means that ReWalk will be listed among all medical devices for compensation, which SHI providers can procure for any approved benef
Jan 05, 2018 04:30 pm ET
ReWalk Robotics Ltd. Appoints Ori Gon as Chief Financial Officer
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 05, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq:RWLK) today announced the Company has appointed its Corporate Controller, Ori Gon as Chief Financial Officer (CFO), effective February...
Nov 30, 2017 09:50 am ET
Correcting and Updating: ReWalk's Restore technology for stroke patients featured in MD&DI
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 30, 2017 /PRNewswire/ -- ReWalk Robotics' (Nasdaq: RWLK) ("ReWalk" or the "Company") innovative Restore soft exoskeleton system was featured in a recent story as one of the cutting edge technologies seeking to help stroke survivors heal and retain critical motor skills.  The story published in Medical Device & Diagnostic Industry (MD&DI), a leading industry trade magazine.
Nov 28, 2017 06:50 am ET
ReWalk Robotics Announces Full Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares in Follow-on Public Offering
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or the “Company”) today announced that National Securities Corporation (“National”), the underwriter of ReWalk’s underwritten public offering of ordinary shares, exercised in full...
Nov 17, 2017 06:50 am ET
ReWalk Robotics Announces Pricing of Follow-on Public Offering of Ordinary Shares
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Nov. 17, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or the “Company”) today announced that it has priced its underwritten public offering of 6,857,000 ordinary shares at a price to...
Nov 02, 2017 07:50 am ET
German National Social Accident Insurance Agrees to Provide Personal Exoskeletons to Qualifying Beneficiaries
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 2, 2017 /PRNewswire/ -- ReWalk Robotics Ltd. ("ReWalk" or the "Company") (Nasdaq: RWLK) today announced that Germany's national social accident insurance provider, Deutsche Gesetzliche Unfallversicherung ("DGUV"), approved the rental of the 20th ReWalk Personal exoskeleton system for qualifying beneficiaries. Additionally, DGUV recently signed a confirmation letter stipulating that DGUV's member payers, including the health insurance association Berufsgenossenschaft (also known as BG) and state insurers, will approve the supply of exoskeleton
Nov 02, 2017 06:55 am ET
ReWalk Robotics Reports Third Quarter 2017 Financial Results
-- 24% YOY growth in Q3 revenue to $1.7 million ---- Coverage allowed by DGUV and Barmer in Germany of ReWalk personal devices --
Oct 16, 2017 09:35 am ET
Soft Suit Exoskeleton Technology Begins Next Phase of Testing in Pre-Clinical Study
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Oct. 16, 2017 /PRNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk") today announced that the soft exosuit technology currently in development has entered the next phase of testing and verification in collaboration with researchers at Harvard University's Wyss Institute for Biologically Inspired Engineering. This phase of testing includes evaluating the ReWalk exosuit system that is based on Wyss Institute exosuit technology with individuals who have had a stroke, in preparation for upcoming clinical trials to be run at clinical sites in 2
Oct 16, 2017 09:30 am ET
ReWalk Completes Critical Design Review Processes of Restore System for Move to Clinical Studies
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Oct. 16, 2017 /PRNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk") announced today completion of all internal processes to initiate clinical studies and the initial production of its "soft suit" exoskeleton design for stroke patients.  Called "Restore," the new system is the first product in the company's expansion into new technologies that will serve mobility-challenged patient communities.  This design is targeted to serve the stroke rehabilitation community.
Sep 14, 2017 09:03 am ET
Payer Coverage for ReWalk Expands in Germany with Barmer
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Sept. 14, 2017 /PRNewswire/ -- ReWalk Robotics Ltd. ("ReWalk" or the "Company") (Nasdaq: RWLK), today announced that one of the leading German insurers, Barmer, has signed a confirmation regarding the provision of ReWalk systems for all qualifying beneficiaries. This confirms the procurement of exoskeletons for users that meet the inclusion criteria and reach successful assessment by the German Medical Service of the Health Insurers (MDK) before and after training
Aug 03, 2017 07:30 am ET
ReWalk Robotics Reports Second Quarter 2017 Financial Results
-- 146% YOY growth in Q2 revenue to $2 million and record 1H revenue of $4.5 million – -- 11 favorable commercial case-by-case insurance coverage decisions -- -- 217 pending insurance claims in the U.S. and Germany -- -- Unveiled Restore soft-exosuit for stroke patients --...
Aug 02, 2017 04:30 pm ET
ReWalk Robotics to Present at Canaccord Genuity Growth Conference 2017
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Aug. 02, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq:RWLK) today announced that Larry Jasinski, Chief Executive Officer, will present at the Canaccord Genuity Growth Conference 2017 in Boston as follows:   ...
Aug 02, 2017 09:03 am ET
Foundational Study Shows Soft Suit Exoskeleton Improves Walking for Stroke Survivors
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Aug. 2, 2017 /PRNewswire-USNewswire/ -- A new study published in the Journal of Science Translational Medicine finds that use of a soft suit exoskeleton system facilitates normal walking ability for ambulatory patients following a stroke. The paper, which is authored by researchers at Harvard University's Wyss Institute for Biologically Inspired Engineering and Boston University, is a seminal study, providing key findings that will propel additional research of how to improve mobility for patients following a stroke. 
Jul 25, 2017 09:03 am ET
ICYMI: TechCrunch Features Restore™ Soft Suit Showcase at MIT's MassRobotics Event
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, July 25, 2017 /PRNewswire/ -- An in-depth story in TechCrunch covers the recent public debut of Restore, the new soft suit exoskeleton created in collaboration by ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk") and Harvard University's Wyss Institute for Biologically Inspired Engineering. 
Jul 11, 2017 06:00 am ET
ReWalk Robotics Announces French Distribution Agreement with Harmonie Médical Service
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, July 11, 2017 /PRNewswire/ -- ReWalk Robotics Ltd. (NASDAQ: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of exoskeleton systems, announced today that the Company has signed a new, exclusive distribution agreement in France with Harmonie Médical Service (HMS). Through the agreement, HMS will serve as the sole distributor of ReWalk exoskeleton systems to qualifying candidates with spinal cord injury (SCI) across France. HMS, one of the largest medical device providers in the country, will be able to distribute both ReWalk Personal syste
Jun 12, 2017 09:30 am ET
Florida Blue Cross Blue Shield to Cover ReWalk Exoskeleton for Paralyzed Plan Member Following Court Decision Deeming the Device Medically Necessary
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, June 12, 2017 /PRNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk"), leading manufacturer of exoskeleton systems, today announced a Florida court ruling that found Blue Cross Blue Shield of Florida must provide coverage of a ReWalk exoskeleton system for a plan member with a spinal cord injury ("SCI").  This court decision is the latest of several in the United States that have ruled in favor of the individual after original denial of claims by commercial insurers.
Apr 28, 2017 09:02 am ET
ReWalk Robotics Names Jodi Gricci Chief Commercial Officer
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 28, 2017 /PRNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk"), leading manufacturer of exoskeleton systems, today announced the appointment of Jodi Gricci to the role of Chief Commercial Officer. Ms. Gricci previously served as Vice President, Global Marketing, Training, and Service while ReWalk established each of these functions to support customers. In addition, the company's overall strategy with supporting the Veteran Affairs department; market development efforts for exoskeleton use for Spinal Cord Injured (SCI) individuals i
Apr 24, 2017 04:30 pm ET
ReWalk Robotics to Discuss 2017 First Quarter Financial Results on May 4, 2017 Conference Call
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 24, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK), a leading manufacturer and producer of exoskeleton systems, will release its 2017 first quarter financial results on Thursday, May 4, 2017, before the U.S. financial markets open.   ...
Apr 06, 2017 09:02 am ET
U.S. Department of Veterans Affairs Purchases 28 Additional ReWalk Exoskeleton Systems to Support National Multi-Center Trial
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., April 6, 2017 /PRNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk"), leading manufacturer and producer of exoskeleton systems, announced today that the U.S. Department of Veterans Affairs (VA) purchased 28 ReWalk Personal Exoskeleton Systems to support an ongoing national multi-center clinical trial. ReWalk confirmed shipment of 20 systems to the VA in the first quarter of 2017; the remaining eight systems from this purchase will be shipped in the second quarter of this year. 
Mar 23, 2017 10:40 am ET
RWLK SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving ReWalk Robotics Ltd. and a Lead Plaintiff Deadline of March 27, 2017
NEW YORK, March 23, 2017 /PRNewswire/ --  The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased ReWalk Robotics Ltd. (NASDAQ: RWLK) securities pursuant and/or traceable to the Company's Stock Offering on or about September 12, 2014.
Mar 17, 2017 11:17 am ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint on Behalf of Investors in ReWalk Robotics Ltd.
NEW YORK, March 17, 2017 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:
Mar 15, 2017 02:32 pm ET
RWLK SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving ReWalk Robotics Ltd. and a Lead Plaintiff Deadline of March 27, 2017
NEW YORK, March 15, 2017 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased ReWalk Robotics Ltd. (NASDAQ:RWLK) securities pursuant and/or traceable to the Company’s Stock Offering on or about September 12, 2014....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.